Who owns LEXEO THERAPEUTICS INC?
- Ticker: LXEO
- CUSIP Number: 52886x107
Tip: Access positions for across all investors
Analyze quarterly positions in Lexeo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lexeo Therapeutics stock
Who bought or sold LEXEO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Eventide Asset Management | 3.0M | $40M | 100% | Dec 2023 |
|
| Henderson Group | 2.3M | $32M | 100% | Dec 2023 |
|
| Omega Fund Management | 2.2M | $29M | 100% | Dec 2023 |
|
| Citadel Advisors | 2.1M | $28M | 100% | Dec 2023 |
|
| Blackstone Group | 696k | $9.3M | 100% | Dec 2023 |
|
| Artal Group | 603k | $8.1M | 100% | Dec 2023 |
|
| Vanguard Group | 416k | $5.6M | 100% | Dec 2023 |
|
| Laurion Capital Management | 255k | $3.4M | 100% | Dec 2023 |
|
| Cornell University | 126k | $2.0M | 100% | Mar 2024 |
|
| Citigroup | 92k | $1.2M | 100% | Dec 2023 |
|
| Millennium Management | 44k | $592k | 100% | Dec 2023 |
|
| Jane Street | 39k | $523k | 100% | Dec 2023 |
|
| Point72 Middle East FZE | 29k | $384k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 28k | $444k | 101% | Mar 2024 |
|
| Cubist Systematic Strategies | 26k | $346k | 100% | Dec 2023 |
|
| Barclays | 16k | $208k | 100% | Dec 2023 |
|
| Legal & General Group | 15k | $202k | 100% | Dec 2023 |
|
| Bank of America Corporation | 8.1k | $109k | 100% | Dec 2023 |
|
| Amalgamated Bank | 623.00 | $10k | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 323.00 | $4.3k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 112.00 | $1.5k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 72.00 | $966.002400 | 100% | Dec 2023 |
|